Baird analyst Jeff Johnson raised the firm’s price target on Cooper Companies to $385 from $371 and keeps an Outperform rating on the shares. The analyst said Q1 was solid across the board, as 10% organic growth for CVI led the contact lens industry. Management also raised 20’23 organic growth expectations for both CVI and CSI and upped EPS guidance by $0.30 at the midpoint.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on COO:
- Cooper Companies sees FY23 EPS $12.60-$12.90, consensus $12.52
- Cooper Companies reports Q4 EPS $2.90, consensus $2.70
- CooperCompanies Announces First Quarter 2023 Results
- Cooper Companies management to meet with Piper Sandler
- CooperCompanies to Present at KeyBanc Life Sciences & MedTech Investor Forum